Correlation Between Regencell Bioscience and Aquestive Therapeutics

Can any of the company-specific risk be diversified away by investing in both Regencell Bioscience and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regencell Bioscience and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regencell Bioscience Holdings and Aquestive Therapeutics, you can compare the effects of market volatilities on Regencell Bioscience and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regencell Bioscience with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regencell Bioscience and Aquestive Therapeutics.

Diversification Opportunities for Regencell Bioscience and Aquestive Therapeutics

0.02

Correlation Coefficient

Regencell Bioscience  Aquestive Therapeutics

Significant diversification

The 3 months correlation between Regencell and Aquestive is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Regencell Bioscience Holdings and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Regencell Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regencell Bioscience Holdings are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Regencell Bioscience i.e., Regencell Bioscience and Aquestive Therapeutics go up and down completely randomly.

Pair Corralation between Regencell Bioscience and Aquestive Therapeutics

Considering the 90-day investment horizon Regencell Bioscience Holdings is expected to generate 7.75 times more return on investment than Aquestive Therapeutics. However, Regencell Bioscience is 7.75 times more volatile than Aquestive Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about -0.04 per unit of risk. If you would invest  482.00  in Regencell Bioscience Holdings on December 30, 2024 and sell it today you would earn a total of  2,085  from holding Regencell Bioscience Holdings or generate 432.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Regencell Bioscience Holdings  vs.  Aquestive Therapeutics

Regencell Bioscience

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Regencell Bioscience Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile technical and fundamental indicators, Regencell Bioscience exhibited solid returns over the last few months and may actually be approaching a breakup point.

Aquestive Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Regencell Bioscience and Aquestive Therapeutics

The main advantage of trading using opposite Regencell Bioscience and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regencell Bioscience position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.

The idea behind Regencell Bioscience Holdings and Aquestive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.